What is Electromed?
Electromed, Inc. specializes in the development, manufacturing, and marketing of airway clearance therapy systems and related medical products. Headquartered in New Prague, the company's flagship offering is the SmartVest airway clearance system, which utilizes an inflatable garment and a programmable air pulse generator to assist patients with compromised pulmonary function. The SmartVest SQL System offers enhanced programmability and features for advanced patient care. Electromed also provides disposable SmartVest and SmartVest Wrap products for use in intensive care settings. The company primarily serves patients suffering from chronic lung conditions such as bronchiectasis, cystic fibrosis, and neuromuscular diseases, marketing its solutions to physicians, healthcare providers, and directly to patients. Founded in 1992, Electromed has established itself as a key player in the respiratory therapy market.
How much funding has Electromed raised?
Electromed has raised a total of $6.8M across 1 funding round:
Stock Offering
$6.8M
Stock Issuance/Offering (2010): $6.8M, investors not publicly disclosed
What's next for Electromed?
The recent major strategic investment signals Electromed's readiness for its next phase of growth, likely focusing on expanding market reach, enhancing product innovation, and potentially exploring new therapeutic applications for its airway clearance technology. Given the enterprise-level funding context, strategic initiatives may include scaling manufacturing capabilities, investing in research and development for next-generation devices, and strengthening its sales and distribution networks both domestically and internationally. This capital infusion is expected to solidify Electromed's competitive advantage and support its mission to improve the lives of individuals with chronic respiratory conditions.
See full Electromed company page
